Breastfeeding moms: new study checks drug levels in milk
NCT ID NCT06867835
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This completed study tested 10 healthy breastfeeding women to see how much of the drug Vyleesi (bremelanotide) passes into breast milk after a single injection. Participants pumped and stored milk before dosing and stopped breastfeeding for the study. Researchers measured drug levels in milk and blood over 24 hours. The goal is to understand if the drug could reach the baby through milk.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Vyleesi (bremelanotide injection)
- What this could lead to
- If results show little drug passes into milk, it may help guide safe use of Vyleesi in breastfeeding mothers.
- What could go wrong
- This is a very small study (10 women) that only looks at a single dose. It cannot determine long-term safety for infants.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LACTATING MOTHER are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
First Excellence Research Group LLC
Doral, Florida, 33178, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.